InvestorInvestor relations

World Hepatitis Day

World Hepatitis Day

For the vast majority of the 325 million people living with hepatitis B and/or C, accessing testing and treatment remains beyond reach.

Of the estimated 257 million living with hepatitis B infection:

  • 10.5% (27 million) knew their infection status in 2016.
  • Of those people diagnosed, only 17% (4.5 million) received treatment in 2016.
  • In 2016, 1.1 million people newly developed chronic hepatitis B infection—a primary cause of liver cancer.

Of the estimated 71 million people living with chronic hepatitis C infection in 2015.

  • 19% (13.1 million) knew their infection status in 2017.
  • Of those people diagnosed, 15% (2 million) received curative treatment in that same year. Overall, between 2014 and 2017, 5 million people have received hepatitis C curative treatment.
  • In 2017, 1.75 million people newly developed chronic hepatitis C infection.


On the eve of World Hepatitis Day on July 28, the World Health Organization (WHO) called on all countries to take advantage of the opportunity to increase investment in the elimination of hepatitis after the cost of diagnosis and treatment of viral hepatitis has recently decreased.

WHO Member States approved WHO global hepatitis strategy that aims to reduce new cases of hepatitis infection by 90% and deaths by 65% between 2016 and 2030. On World Hepatitis Day 2019, WHO calls on all countries to "invest in the elimination of hepatitis" by accounting, budgeting and providing funds for the elimination of hepatitis services in their national health coverage plans. WHO Member States widely support the adoption of WHO's hepatitis elimination strategy, but only 124 of 194 member states have hepatitis plans, and more than 40% of the national plans do not specify special budget items to support the elimination work.

TAG:  Hualan Bio, World Hepatitis Day, Hepatitis B and/or C, Infection, Elimination of hepatitis, Investment, Hepatitis elimination strategy